急诊晕厥患者的心脏生物标志物、超声心动图与门诊心脏监测:SAEM GRACE 直接证据的系统评价与分析
该系统评价评估了急诊成人晕厥患者中肌钙蛋白、B型利钠肽(BNP)、经胸超声心动图(TTE)和门诊心脏监测的诊断准确性。共纳入41项研究(21,557例患者),异质性大(所有I²>90%)无法进行Meta分析。BNP的阳性似然比(LR+)为1.4-47,阴性似然比(LR-)为0.06-0.4;肌钙蛋白的LR+为1.9-11.2,LR-为0.2-0.9。TTE诊断阳性率总体为0%-29%,高危组为8%-28%;门诊监测总体为1%-59%,高危组为12%-42%。基于现有证据,这些检查单独不能推荐用于晕厥的常规评估。
要点
- 在急诊晕厥患者中,BNP的LR+为1.4-47,LR-为0.06-0.4;肌钙蛋白的LR+为1.9-11.2,LR-为0.2-0.9,因异质性大(所有I²>90%)无法汇总。
- TTE的诊断阳性率总体为0%-29%,在高危组为8%-28%。
- 门诊心脏监测的诊断阳性率总体为1%-59%,在高危组为12%-42%。
- 基于现有证据,这些检查单独不能推荐用于晕厥的常规评估。
- 在有心脏危险因素的患者中,TTE和门诊监测的诊断阳性率更高。
适用人群与场景
- 急诊成人晕厥患者。
研究设计与关键结果
- 系统评价纳入41项研究,共21,557例患者。
- BNP的LR+为1.4-47,LR-为0.06-0.4。
- 肌钙蛋白的LR+为1.9-11.2,LR-为0.2-0.9。
- TTE诊断阳性率总体为0%-29%,高危组为8%-28%。
- 门诊心脏监测诊断阳性率总体为1%-59%,高危组为12%-42%。
- 所有纳入研究的异质性I²>90%,无法进行Meta分析。
证据类型、等级与局限
- 证据类型:系统评价。
- 使用JBI和QUADAS-2评估偏倚风险。
- 局限:所有纳入研究异质性I²>90%,无法进行Meta分析。
对床旁实践的改变
- 基于现有证据,这些检查单独不能推荐用于晕厥的常规评估。
- 在有心脏危险因素的患者中,TTE和门诊监测的诊断阳性率更高,可能有助于更准确的诊断。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Syncope places a significant burden on emergency departments (EDs), often prompting extensive testing to exclude life-threatening conditions. However, the diagnostic utility of troponin, B-type natriuretic peptide (BNP), transthoracic echocardiography (TTE), and outpatient cardiac monitoring remains unclear.
METHODS: This systematic review assessed the diagnostic accuracy of these tests in adults presenting with syncope. The research question was: In ED patients with syncope, does TTE, cardiac biomarkers (troponin, BNP), or outpatient arrhythmia monitoring, compared with no testing, improve outcomes within 30 days? Primary outcomes included adverse events (death, arrhythmias, structural/ischemic heart disease, and select non-cardiac causes such as pulmonary embolism or aortic dissection) for biomarkers and diagnostic yield for TTE and monitoring. Sensitivity, specificity, and likelihood ratios (LR+ and LR-) were calculated for biomarkers, while diagnostic yield with 95% CI was reported for TTE and monitoring. Risk of bias was assessed using JBI and QUADAS-2.
RESULTS: The database searches identified 1759 citations. After applying inclusion and exclusion criteria, 41 studies (21,557 patients) were included. Significant heterogeneity among the included trials (all with I2 > 90%) precluded meta-analysis. For BNP, LR+ ranged 1.4-47 and LR- 0.06-0.4; for troponin, LR+ 1.9-11.2 and LR- 0.2-0.9. TTE diagnostic yield was 0%-29% overall and 8%-28% in high-risk groups. Outpatient monitoring yielded 1%-59% overall and 12%-42% in high-risk patients.
CONCLUSION: In ED patients with syncope, the diagnostic accuracy and yield of cardiac biomarkers, TTE, and outpatient monitoring show substantial variability, largely due to differences in patient populations, outcome measures, and study methodologies. Based on the existing evidence, these modalities in isolation cannot be recommended for routine use in syncope evaluation. Among these tests, the diagnostic yield of TTE and outpatient monitoring is greater in patients with cardiac risk factors and could potentially contribute to a more accurate diagnosis.
参考来源
- Benabbas R, Zehtabchi S, Wakai A, et al. Cardiac Biomarkers, Echocardiography, and Outpatient Cardiac Monitoring for Evaluation of Emergency Department Patients With Syncope: A Systematic Review and Analysis of Direct Evidence for SAEM GRACE. Acad Emerg Med. 2025. PMID: 41201260. doi:10.1111/acem.70175
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。